JNJ-47910382

N/A

Report date: 2024/01/25 09:17:37
NME

Base Information

Drug NameJNJ-47910382
Drug Alias NameJNJ-47910382
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus NS 5 protein inhibitors
TargetsHepatitis C virus NS 5 protein
Therapy Area/IndicationsHepatitis C, ChronicHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumTaiwanGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen R&D Ireland
Active IndicationsN/A
Inactive IndicationsHepatitis C, ChronicHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A